REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $145,803 | +30.4% | 1,430,004 | +16.3% | 6.76% | +23.1% |
| Q1 2023 | $111,832 | -99.8% | 1,230,004 | 0.0% | 5.49% | +123.1% |
| Q4 2022 | $46,727,852 | +50.1% | 1,230,004 | -0.7% | 2.46% | +40.7% |
| Q3 2022 | $31,136,000 | -17.3% | 1,239,000 | 0.0% | 1.75% | -26.6% |
| Q2 2022 | $37,653,000 | -7.2% | 1,239,000 | 0.0% | 2.38% | +14.3% |
| Q1 2022 | $40,590,000 | +1347.1% | 1,239,000 | +2378.0% | 2.09% | +501.2% |
| Q4 2018 | $2,805,000 | -91.4% | 50,000 | -87.5% | 0.35% | -90.4% |
| Q3 2018 | $32,704,000 | +187.8% | 400,000 | +23.1% | 3.63% | +182.0% |
| Q2 2018 | $11,365,000 | +70.5% | 325,000 | 0.0% | 1.29% | +80.8% |
| Q1 2018 | $6,666,000 | +7.2% | 325,000 | +62.5% | 0.71% | -49.7% |
| Q3 2017 | $6,220,000 | – | 200,000 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |